Literature DB >> 24183826

Anhedonia, avolition, and anticipatory deficits: assessments in animals with relevance to the negative symptoms of schizophrenia.

Samuel A Barnes1, Andre Der-Avakian1, Athina Markou2.   

Abstract

Schizophrenia represents a complex, heterogeneous disorder characterized by several symptomatic domains that include positive and negative symptoms and cognitive deficits. Negative symptoms reflect a cluster of symptoms that remains therapeutically unresponsive to currently available medications. Therefore, the development of animal models that may contribute to the discovery of novel and efficacious treatment strategies is essential. An animal model consists of both an inducing condition or manipulation (i.e., independent variable) and an observable measure(s) (i.e., dependent variables) that are used to assess the construct(s) under investigation. The objective of this review is to describe currently available experimental procedures that can be used to characterize constructs relevant to the negative symptoms of schizophrenia in experimental animals. While negative symptoms can encompass aspects of social withdrawal and emotional blunting, this review focuses on the assessment of reward deficits that result in anhedonia, avolition, and abnormal reward anticipation. The development and utilization of animal procedures that accurately assess reward-based constructs related to negative symptomatology in schizophrenia will provide an improved understanding of the neural substrates involved in these processes.
© 2013 Published by Elsevier B.V. and ECNP.

Entities:  

Keywords:  Animal models; Brain reward; Contrast effects; Effort-related choice; ICSS; Sucrose preference

Mesh:

Year:  2013        PMID: 24183826      PMCID: PMC3986268          DOI: 10.1016/j.euroneuro.2013.10.001

Source DB:  PubMed          Journal:  Eur Neuropsychopharmacol        ISSN: 0924-977X            Impact factor:   4.600


  102 in total

Review 1.  A new perspective on anhedonia in schizophrenia.

Authors:  Gregory P Strauss; James M Gold
Journal:  Am J Psychiatry       Date:  2012-04       Impact factor: 18.112

Review 2.  Effort-related functions of nucleus accumbens dopamine and associated forebrain circuits.

Authors:  J D Salamone; M Correa; A Farrar; S M Mingote
Journal:  Psychopharmacology (Berl)       Date:  2007-01-16       Impact factor: 4.530

3.  The NIMH-MATRICS consensus statement on negative symptoms.

Authors:  Brian Kirkpatrick; Wayne S Fenton; William T Carpenter; Stephen R Marder
Journal:  Schizophr Bull       Date:  2006-02-15       Impact factor: 9.306

4.  Postcocaine anhedonia. An animal model of cocaine withdrawal.

Authors:  A Markou; G F Koob
Journal:  Neuropsychopharmacology       Date:  1991-01       Impact factor: 7.853

5.  Nucleus accumbens dopamine depletions alter relative response allocation in a T-maze cost/benefit task.

Authors:  M S Cousins; A Atherton; L Turner; J D Salamone
Journal:  Behav Brain Res       Date:  1996-01       Impact factor: 3.332

6.  Stress-induced anhedonia in mice is associated with deficits in forced swimming and exploration.

Authors:  Tatyana Strekalova; Rainer Spanagel; Dusan Bartsch; Fritz A Henn; Peter Gass
Journal:  Neuropsychopharmacology       Date:  2004-11       Impact factor: 7.853

7.  Transient and selective overexpression of dopamine D2 receptors in the striatum causes persistent abnormalities in prefrontal cortex functioning.

Authors:  Christoph Kellendonk; Eleanor H Simpson; H Jonathan Polan; Gaël Malleret; Svetlana Vronskaya; Vanessa Winiger; Holly Moore; Eric R Kandel
Journal:  Neuron       Date:  2006-02-16       Impact factor: 17.173

Review 8.  Negative symptoms in schizophrenia: avolition and Occam's razor.

Authors:  George Foussias; Gary Remington
Journal:  Schizophr Bull       Date:  2008-07-21       Impact factor: 9.306

9.  Dopamine, effort, and decision making: theoretical comment on Bardgett et al. (2009).

Authors:  John D Salamone
Journal:  Behav Neurosci       Date:  2009-04       Impact factor: 1.912

10.  Dissociation of hedonic reaction to reward and incentive motivation in an animal model of the negative symptoms of schizophrenia.

Authors:  Ryan D Ward; Eleanor H Simpson; Vanessa L Richards; Gita Deo; Kathleen Taylor; John I Glendinning; Eric R Kandel; Peter D Balsam
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

View more
  22 in total

Review 1.  Translational Assessment of Reward and Motivational Deficits in Psychiatric Disorders.

Authors:  Andre Der-Avakian; Samuel A Barnes; Athina Markou; Diego A Pizzagalli
Journal:  Curr Top Behav Neurosci       Date:  2016

2.  GlyT-1 Inhibition Attenuates Attentional But Not Learning or Motivational Deficits of the Sp4 Hypomorphic Mouse Model Relevant to Psychiatric Disorders.

Authors:  Jared W Young; Mary E Kamenski; Kerin K Higa; Gregory A Light; Mark A Geyer; Xianjin Zhou
Journal:  Neuropsychopharmacology       Date:  2015-04-24       Impact factor: 7.853

3.  Human iPSC Glial Mouse Chimeras Reveal Glial Contributions to Schizophrenia.

Authors:  Martha S Windrem; Mikhail Osipovitch; Zhengshan Liu; Janna Bates; Devin Chandler-Militello; Lisa Zou; Jared Munir; Steven Schanz; Katherine McCoy; Robert H Miller; Su Wang; Maiken Nedergaard; Robert L Findling; Paul J Tesar; Steven A Goldman
Journal:  Cell Stem Cell       Date:  2017-07-20       Impact factor: 24.633

Review 4.  Preclinical Models to Investigate Mechanisms of Negative Symptoms in Schizophrenia.

Authors:  Samuel A Barnes; Andre Der-Avakian; Jared W Young
Journal:  Schizophr Bull       Date:  2017-07-01       Impact factor: 9.306

5.  Athina Markou's contributions to treatment development for mental illnesses: a perspective.

Authors:  Lois Winsky; Linda S Brady
Journal:  Psychopharmacology (Berl)       Date:  2016-11-24       Impact factor: 4.530

6.  Special issue: recognizing the lifetime scientific contributions of Athina Markou.

Authors:  John F Cryan; Harriet de Wit
Journal:  Psychopharmacology (Berl)       Date:  2017-05       Impact factor: 4.530

7.  Decreasing GABA function within the medial prefrontal cortex or basolateral amygdala decreases sociability.

Authors:  Tracie A Paine; Nathan Swedlow; Lucien Swetschinski
Journal:  Behav Brain Res       Date:  2016-10-11       Impact factor: 3.332

8.  Parvalbumin-containing GABA cells and schizophrenia: experimental model based on targeted gene delivery through adeno-associated viruses.

Authors:  Marta U Woloszynowska-Fraser; Peer Wulff; Gernot Riedel
Journal:  Behav Pharmacol       Date:  2017-12       Impact factor: 2.293

9.  Modeling hypohedonia following repeated social defeat: Individual vulnerability and dopaminergic involvement.

Authors:  Samantha R Spierling; Maegan Mattock; Eric P Zorrilla
Journal:  Physiol Behav       Date:  2017-04-19

10.  Apathy but not diminished expression in schizophrenia is associated with discounting of monetary rewards by physical effort.

Authors:  Matthias N Hartmann; Oliver M Hager; Anna V Reimann; Justin R Chumbley; Matthias Kirschner; Erich Seifritz; Philippe N Tobler; Stefan Kaiser
Journal:  Schizophr Bull       Date:  2014-07-22       Impact factor: 9.306

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.